Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-31 @ 3:52 PM
Study NCT ID:
NCT00789633
Status:
COMPLETED
Last Update Posted:
2018-12-17
First Post:
2008-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D010190', 'term': 'Pancreatic Neoplasms'}], 'ancestors': [{'id': 'D004067', 'term': 'Digestive System Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D004701', 'term': 'Endocrine Gland Neoplasms'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D010182', 'term': 'Pancreatic Diseases'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C526575', 'term': 'masitinib'}, {'id': 'D000093542', 'term': 'Gemcitabine'}], 'ancestors': [{'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D003841', 'term': 'Deoxycytidine'}, {'id': 'D003562', 'term': 'Cytidine'}, {'id': 'D011741', 'term': 'Pyrimidine Nucleosides'}, {'id': 'D011743', 'term': 'Pyrimidines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 353}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2008-11-25', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-12', 'dispFirstSubmitDate': '2018-12-12', 'completionDateStruct': {'date': '2012-08-31', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-12-13', 'studyFirstSubmitDate': '2008-11-12', 'dispFirstSubmitQcDate': '2018-12-13', 'studyFirstSubmitQcDate': '2008-11-12', 'dispFirstPostDateStruct': {'date': '2018-12-17', 'type': 'ACTUAL'}, 'lastUpdatePostDateStruct': {'date': '2018-12-17', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2008-11-13', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2011-12-23', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Overall Survival (OS)', 'timeFrame': 'From day of randomization to the date of death, assessed up to 60 months', 'description': 'Overall survival is defined as time in months from the randomization date to the date of death due to any cause. If a patient is not known to have died, then OS will be censored at the date of last known date patient alive.'}], 'secondaryOutcomes': [{'measure': 'Survival rate', 'timeFrame': 'Every 24 weeks, assessed up to 60 months', 'description': 'Defined as the proportion of patients alive at each time point, estimated with Kaplan-Meier distribution.'}, {'measure': 'Progression Free Survival (PFS)', 'timeFrame': 'From day of randomization to disease progression or death, whichever came first, assessed up to 60 months', 'description': 'Progression Free Survival is defined as the time from the randomization date until the date of earliest evidence of disease progression or death, for participants who progressed or died before subsequent cancer therapy. Disease progression will be assessed by the investigator on CT scan according to RECIST 1.1 criteria.'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Pancreatic cancer', 'Advanced pancreatic cancer', 'Metastatic pancreatic cancer', 'Gemcitabine', 'Chemo-naive'], 'conditions': ['Pancreatic Cancer']}, 'referencesModule': {'references': [{'pmid': '25858497', 'type': 'RESULT', 'citation': 'Deplanque G, Demarchi M, Hebbar M, Flynn P, Melichar B, Atkins J, Nowara E, Moye L, Piquemal D, Ritter D, Dubreuil P, Mansfield CD, Acin Y, Moussy A, Hermine O, Hammel P. A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer. Ann Oncol. 2015 Jun;26(6):1194-1200. doi: 10.1093/annonc/mdv133. Epub 2015 Apr 9.'}], 'seeAlsoLinks': [{'url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516046/', 'label': 'Link to article'}]}, 'descriptionModule': {'briefSummary': 'The objective of this study is to compare the efficacy and safety of masitinib in combination with gemcitabine to placebo in combination with gemcitabine in patients with advanced/metastatic pancreatic cancer.', 'detailedDescription': 'Human pancreatic cancer overexpresses a number of important tyrosine kinase (TK) growth factors receptors and ligands, including expression of both PDGF and PDGF receptors. Drugs that can selectively inhibit TKs are likely to be of benefit in pancreatic cancer. Masitinib is a TK inhibitor, selectively and effectively inhibiting c-Kit (mast cell growth factor receptor), PDGF receptor, FGF receptor and to a lower extent the FAK kinases. Pre-clinical and clinical studies have shown that masitinib can reverse resistance of pancreatic tumor cell lines to gemcitabine. Based on pre-clinical and phase 2 clinical studies, masitinib can be considered as a good candidate to use in combination with gemcitabine in the treatment of pancreatic cancer.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Main Inclusion Criteria:\n\n1. Histologically or cytologically confirmed adenocarcinoma of the pancreas\n2. Chemo naïve patients with advanced/metastatic disease\n3. Documented decision justifying non eligibility for surgical resection. The documentation of the non eligibility for surgical resection will be reviewed by an independent committee.\n4. Men and women, age \\>18 years\n5. Men and women of childbearing potential (entering the study after a confirmed menstrual period and who have a negative pregnancy test), must agree to use two methods (one for the patient and one for the partner) of medically acceptable forms of contraception during the study and for 3 months after the last treatment intake.\n6. Patient should be able and willing to comply with study visits and procedures as per protocol.\n7. Patient should understand, sign, and date the written voluntary informed consent form at the screening visit prior to any protocol-specific procedures performed.\n\nMain Exclusion Criteria:\n\n1. Patient treated for a cancer other than pancreatic cancer within 5 years before enrollment, with the exception of basal cell carcinoma or in situ cervical cancer\n2. Any condition that the physician judges could be detrimental to subjects participating in this study; including any clinically important deviations from normal clinical laboratory values or concurrent medical events Previous treatment\n3. Any anti-tumor therapy (any chemotherapy, radiotherapy, immunotherapy, biologic or hormonal therapy) within 6 months prior to baseline\n4. Treatment with any investigational agent within 4 weeks prior to baseline'}, 'identificationModule': {'nctId': 'NCT00789633', 'briefTitle': 'Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer', 'organization': {'class': 'INDUSTRY', 'fullName': 'AB Science'}, 'officialTitle': 'A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled, 2-parallel Group, Phase III Study to Compare Efficacy and Safety of Masitinib 9 mg/kg/Day in Combination With Gemcitabine Compared to Placebo in Combination With Gemcitabine in Treatment of Patients With Advanced/Metastatic Pancreatic Cancer', 'orgStudyIdInfo': {'id': 'AB07012'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Masitinib & gemcitabine', 'description': 'Participants receive masitinib (9 mg/kg/day), given orally twice daily, plus gemcitabine at 1000mg/m2 by intravenous infusion during 30 minutes, once every 7 days, for up to 7 weeks, followed by a week of rest. Subsequent cycles should consist of an IV infusion, once every 7 days, for 3 consecutive weeks out of every 4 weeks, until disease progression, death, limiting toxicity or patient consent withdrawal.', 'interventionNames': ['Drug: Masitinib', 'Drug: Gemcitabine']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo & gemcitabine', 'description': 'Participants receive matching placebo, given orally twice daily, plus gemcitabine at 1000mg/m2 by intravenous infusion during 30 minutes, once every 7 days, for up to 7 weeks, followed by a week of rest. Subsequent cycles should consist of an IV infusion, once every 7 days, for 3 consecutive weeks out of every 4 weeks, until disease progression, death, limiting toxicity or patient consent withdrawal.', 'interventionNames': ['Drug: Placebo', 'Drug: Gemcitabine']}], 'interventions': [{'name': 'Masitinib', 'type': 'DRUG', 'otherNames': ['AB1010'], 'description': 'Masitinib at 9 mg/kg/day given orally twice daily', 'armGroupLabels': ['Masitinib & gemcitabine']}, {'name': 'Placebo', 'type': 'DRUG', 'description': 'Matching placebo given orally twice daily', 'armGroupLabels': ['Placebo & gemcitabine']}, {'name': 'Gemcitabine', 'type': 'DRUG', 'otherNames': ['Gemzar'], 'description': 'Gemcitabine at 1000 mg/m2 by intravenous infusion', 'armGroupLabels': ['Masitinib & gemcitabine', 'Placebo & gemcitabine']}]}, 'contactsLocationsModule': {'locations': [{'zip': '06360', 'city': 'Norwich', 'state': 'Connecticut', 'country': 'United States', 'facility': 'Eastern Connecticut Hematology and Oncology (ECHO)', 'geoPoint': {'lat': 41.52426, 'lon': -72.07591}}, {'zip': '32806', 'city': 'Orlando', 'state': 'Florida', 'country': 'United States', 'facility': 'MD Anderson', 'geoPoint': {'lat': 28.53834, 'lon': -81.37924}}, {'zip': '30322', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'The Emory Clinic', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '62526', 'city': 'Decatur', 'state': 'Illinois', 'country': 'United States', 'facility': 'Decatur Memorial Hospital', 'geoPoint': {'lat': 39.84031, 'lon': -88.9548}}, {'zip': '61401', 'city': 'Galesburg', 'state': 'Illinois', 'country': 'United States', 'facility': 'Medical & Surgical Specialists', 'geoPoint': {'lat': 40.94782, 'lon': -90.37124}}, {'zip': '01201', 'city': 'Pittsfield', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Berkshire Hematology Oncology', 'geoPoint': {'lat': 42.45008, 'lon': -73.24538}}, {'zip': '48202', 'city': 'Detroit', 'state': 'Michigan', 'country': 'United States', 'facility': 'Henry Ford Health System', 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'zip': '55416', 'city': 'Saint Louis Park', 'state': 'Minnesota', 'country': 'United States', 'facility': 'Metro MN CCOP', 'geoPoint': {'lat': 44.9483, 'lon': -93.34801}}, {'zip': '64111', 'city': 'Kansas City', 'state': 'Missouri', 'country': 'United States', 'facility': "Saint Luke's Cancer Institute", 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '07652', 'city': 'Paramus', 'state': 'New Jersey', 'country': 'United States', 'facility': 'The Valley Hospital', 'geoPoint': {'lat': 40.94454, 'lon': -74.07542}}, {'zip': '27534', 'city': 'Goldsboro', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Southeastern Medical Oncology Center', 'geoPoint': {'lat': 35.38488, 'lon': -77.99277}}, {'zip': '97239', 'city': 'Portland', 'state': 'Oregon', 'country': 'United States', 'facility': 'Oregon Health & Science University', 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'zip': '625 00', 'city': 'Brno', 'country': 'Czechia', 'facility': 'Teaching Hospital Brno-Bohunice', 'geoPoint': {'lat': 49.19522, 'lon': 16.60796}}, {'zip': '430 12', 'city': 'Chomutov', 'country': 'Czechia', 'facility': 'Hospital Chomutov', 'geoPoint': {'lat': 50.46048, 'lon': 13.41779}}, {'zip': '284 30', 'city': 'Kutná Hora', 'country': 'Czechia', 'facility': 'Oncology Surgery', 'geoPoint': {'lat': 49.94839, 'lon': 15.26816}}, {'zip': '775 20', 'city': 'Olomouc', 'country': 'Czechia', 'facility': 'Department of Oncology Teaching Hospital Olomouc', 'geoPoint': {'lat': 49.59552, 'lon': 17.25175}}, {'zip': '100 34', 'city': 'Prague', 'country': 'Czechia', 'facility': 'Teaching Hospital Královské', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '180 81', 'city': 'Prague', 'country': 'Czechia', 'facility': 'Teaching Hospital Na Bulovce', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '5 150 30', 'city': 'Prague', 'country': 'Czechia', 'facility': 'Hospital na Homolce', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '80000', 'city': 'Amiens', 'country': 'France', 'facility': 'CHU Amiens', 'geoPoint': {'lat': 49.9, 'lon': 2.3}}, {'zip': '92160', 'city': 'Antony', 'country': 'France', 'facility': "Hôpital Privé d'Antony", 'geoPoint': {'lat': 48.75329, 'lon': 2.29668}}, {'zip': '84000', 'city': 'Avignon', 'country': 'France', 'facility': 'Institut Sainte-Catherine', 'geoPoint': {'lat': 43.94834, 'lon': 4.80892}}, {'city': 'Besançon', 'country': 'France', 'facility': 'Hôpital Jean Minjoz', 'geoPoint': {'lat': 47.24878, 'lon': 6.01815}}, {'city': 'Bordeaux', 'country': 'France', 'facility': 'Hôpital Saint-André', 'geoPoint': {'lat': 44.84124, 'lon': -0.58046}}, {'zip': '29600', 'city': 'Brest', 'country': 'France', 'facility': 'CHU de la Cavale Blanche', 'geoPoint': {'lat': 48.39029, 'lon': -4.48628}}, {'zip': '14000', 'city': 'Caen', 'country': 'France', 'facility': 'CHU de Caen', 'geoPoint': {'lat': 49.18585, 'lon': -0.35912}}, {'zip': '63000', 'city': 'Clermont-Ferrand', 'country': 'France', 'facility': 'CHU Hôtel Dieu', 'geoPoint': {'lat': 45.77969, 'lon': 3.08682}}, {'zip': '92', 'city': 'Clichy', 'country': 'France', 'facility': 'Groupement Hospitalier Universitaire Nord - Beaujon', 'geoPoint': {'lat': 48.90018, 'lon': 2.30952}}, {'zip': '94000', 'city': 'Créteil', 'country': 'France', 'facility': 'CHU Henri Mondor', 'geoPoint': {'lat': 48.79266, 'lon': 2.46569}}, {'city': 'Créteil', 'country': 'France', 'facility': 'CHU Henri Mondor', 'geoPoint': {'lat': 48.79266, 'lon': 2.46569}}, {'city': 'Dreux', 'country': 'France', 'facility': 'Hôpital Victor Jousselin', 'geoPoint': {'lat': 48.73649, 'lon': 1.36566}}, {'zip': '45500', 'city': 'Gien', 'country': 'France', 'facility': 'Centre Gastro-Loire', 'geoPoint': {'lat': 47.69332, 'lon': 2.63094}}, {'zip': '38000', 'city': 'Grenoble', 'country': 'France', 'facility': 'Institut Daniel Hollard', 'geoPoint': {'lat': 45.17869, 'lon': 5.71479}}, {'zip': '85925', 'city': 'La Roche-sur-Yon', 'country': 'France', 'facility': 'CHD Les Oudairies', 'geoPoint': {'lat': 46.66974, 'lon': -1.42757}}, {'zip': '78150', 'city': 'Le Chesnay', 'country': 'France', 'facility': 'Hôpital André Mignot', 'geoPoint': {'lat': 48.8222, 'lon': 2.12213}}, {'zip': '33500', 'city': 'Libourne', 'country': 'France', 'facility': 'Hôpital Robert Boulin', 'geoPoint': {'lat': 44.91449, 'lon': -0.24186}}, {'zip': '59000', 'city': 'Lille', 'country': 'France', 'facility': 'Hôpital Claude Huriez', 'geoPoint': {'lat': 50.63391, 'lon': 3.05512}}, {'zip': '91164', 'city': 'Longjumeau', 'country': 'France', 'facility': 'Centre Hospitalier de Longjumeau', 'geoPoint': {'lat': 48.69307, 'lon': 2.29431}}, {'zip': '69000', 'city': 'Lyon', 'country': 'France', 'facility': 'Hôpital Privé Jean Mermoz', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'zip': '69003', 'city': 'Lyon', 'country': 'France', 'facility': 'Hôpital Edouard Herriot', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'city': 'Lyon', 'country': 'France', 'facility': 'Centre Léon Bérard', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'zip': '13000', 'city': 'Marseille', 'country': 'France', 'facility': 'Assistance Publique des Hôpitaux de Marseille', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'zip': '13000', 'city': 'Marseille', 'country': 'France', 'facility': 'Hôpital Saint Joseph', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'zip': '25200', 'city': 'Montbéliard', 'country': 'France', 'facility': 'Centre Hospitalier Belfort - Montbéliard', 'geoPoint': {'lat': 47.50957, 'lon': 6.79823}}, {'zip': '44000', 'city': 'Nantes', 'country': 'France', 'facility': 'CHU Hôtel Dieu', 'geoPoint': {'lat': 47.21725, 'lon': -1.55336}}, {'zip': '44200', 'city': 'Nantes', 'country': 'France', 'facility': 'Centre Catherine de Sienne', 'geoPoint': {'lat': 47.21725, 'lon': -1.55336}}, {'zip': '45000', 'city': 'Orléans', 'country': 'France', 'facility': 'Hôpital de la Source', 'geoPoint': {'lat': 47.90248, 'lon': 1.90407}}, {'zip': '75000', 'city': 'Paris', 'country': 'France', 'facility': 'Groupe Hospitalier Diaconesse Croix Saint Simon', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'zip': '75020', 'city': 'Paris', 'country': 'France', 'facility': 'Hôpital Tenon', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'city': 'Paris', 'country': 'France', 'facility': 'Hôpital Hôtel Dieu', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'city': 'Paris', 'country': 'France', 'facility': 'Hôpital Saint-Joseph', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'zip': '33600', 'city': 'Pessac', 'country': 'France', 'facility': 'Hôpital Haut-Lévêque', 'geoPoint': {'lat': 44.80565, 'lon': -0.6324}}, {'zip': '24000', 'city': 'Périgueux', 'country': 'France', 'facility': 'Polyclinique Francheville', 'geoPoint': {'lat': 45.18691, 'lon': 0.71439}}, {'zip': '67200', 'city': 'Strasbourg', 'country': 'France', 'facility': 'Hôpital Hautepierre', 'geoPoint': {'lat': 48.58392, 'lon': 7.74553}}, {'zip': '54500', 'city': 'Vandœuvre-lès-Nancy', 'country': 'France', 'facility': 'CHU Brabois', 'geoPoint': {'lat': 48.66115, 'lon': 6.17114}}, {'zip': '94800', 'city': 'Villejuif', 'country': 'France', 'facility': 'Hôpital Paul Brousse', 'geoPoint': {'lat': 48.7939, 'lon': 2.35992}}, {'city': 'Beirut', 'country': 'Lebanon', 'facility': 'Hotel Dieu de France', 'geoPoint': {'lat': 33.89332, 'lon': 35.50157}}, {'city': 'Beirut', 'country': 'Lebanon', 'facility': 'Makassed General Hospital Tarik Jadide', 'geoPoint': {'lat': 33.89332, 'lon': 35.50157}}, {'city': 'Beirut', 'country': 'Lebanon', 'facility': 'Rafik Hariri University Hospital', 'geoPoint': {'lat': 33.89332, 'lon': 35.50157}}, {'city': 'Beirut', 'country': 'Lebanon', 'facility': 'Saint Georges Hospital UMC', 'geoPoint': {'lat': 33.89332, 'lon': 35.50157}}, {'city': 'Metn', 'country': 'Lebanon', 'facility': 'Middle East Institute of Health- Bsaleem'}, {'city': 'Metn', 'country': 'Lebanon', 'facility': 'Saint Joseph Hospital Baouchrieh'}, {'city': 'Saida', 'country': 'Lebanon', 'facility': 'Hammoud Hospital University Medical Center', 'geoPoint': {'lat': 33.55751, 'lon': 35.37148}}, {'zip': '310013', 'city': 'Arad', 'country': 'Romania', 'facility': 'Municipal Clinical Hospital', 'geoPoint': {'lat': 46.18333, 'lon': 21.31667}}, {'zip': '430031', 'city': 'Baia Mare', 'country': 'Romania', 'facility': 'County Hospital', 'geoPoint': {'lat': 47.65729, 'lon': 23.56808}}, {'zip': '900591', 'city': 'Constanța', 'country': 'Romania', 'facility': 'Emergency Clinical Hospital', 'geoPoint': {'lat': 44.18073, 'lon': 28.63432}}, {'zip': '410548', 'city': 'Pelica Impex', 'country': 'Romania', 'facility': 'Pelica Impex SRL Hospital'}, {'zip': '440056', 'city': 'Satu Mare', 'country': 'Romania', 'facility': 'County Hospital', 'geoPoint': {'lat': 47.79926, 'lon': 22.86255}}], 'overallOfficials': [{'name': 'Gaël Deplanque, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Hôpital Saint Joseph, Paris, France'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'AB Science', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}